We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Study Supports Body Area Sensory Networks for Diagnostic Monitoring

By LabMedica International staff writers
Posted on 26 Aug 2019
The first steps have been taken on the path leading to development of a body area sensor network, which is a collection of networked sensors that can be used to remotely monitor human physiological signals.

For its application in next-generation personalized healthcare systems, stretchable on-skin sensors have to be seamlessly meshed with rigid silicon readout circuits. More...
Toward this end, investigators at Stanford University (Palo Alto, CA, USA) devleoped a body area sensory network (a bodyNET) composed of chip-free and battery-free stretchable on-skin sensor tags that were wirelessly linked to flexible readout circuits attached to clothing. This design offered a conformal skin-mimicking interface by removing all direct contacts between rigid components and the human body. Thus, this design addressed the mechanical incompatibility issue between soft on-skin devices and rigid high-performance silicon electronics.

For communications between the skin sensors and the clothing-bound receivers, the investigators introduced an unconventional radiofrequency identification technology where the wireless sensors were deliberately detuned to increase the tolerance of strain-induced changes in electronic properties. Thus, the bodyNET comprised chip-free and battery-free stretchable on-skin sensor tags, which had been screen-printed with metallic ink, that were wirelessly linked to flexible readout circuits attached to textiles.

The investigators used this prototype bodyNET to simultaneously and continuously analyse an individual’s pulse, breath, and body movement.

Ultimately, it is intended that this technology evolve into a device that would be comfortable to wear and have no batteries or rigid circuits to prevent the body sensors from stretching and contracting with the skin in response to changes in the subject’s physiology.

"We think one day it will be possible to create a full-body skin-sensor array to collect physiological data without interfering with a person's normal behavior," said senior author Dr. Zhenan Bao, professor of chemical engineering at Stanford University.

The bodyNET concept was discussed in a paper published in the August 15, 2019, online edition of the journal Nature Electronics.

Related Links:
Stanford University


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.